INTRODUCTION
Uric acid is constitutively present in normal cells, increased in concentration when cells are injured, and released from dying cells 1 . Based on a theory proposed by Matzinger, the products of cell stress and tissue damage may represent "danger signals" that function as endogenous adjuvants recognized by the immune system 2 .
Shi subsequently identified uric acid (UA) as one of these principal endogenous "danger signals" released from injured cells and mediating the immune response to antigens associated with injured cells 1 . These data form the basis for our hypothesis that elevated synovial fluid (SF) uric acid may be a potentiating factor in osteoarthritis (OA).
METHODS
Patients: A total of 159 participants were enrolled in the NIH sponsored Strategies to Predict Osteoarthritis Progression (POP) study. Informed consent was obtained from all subjects and the entire study was approved by the Duke University Institutional Review Board. Participants met the ACR criteria for symptomatic OA of at least one knee. All participants met radiographic criteria for OA with a Kellgren-Lawrence (KL) score of 1-4 in at least one knee 3 . Exclusion criteria included the following: bilateral knee KL4 scores; exposure to a corticosteroid within 3 months prior; knee arthroscopic surgery within 6 months prior; known history of avascular necrosis, inflammatory arthritis, Paget's disease, joint infection, periarticular fracture, neuropathic arthropathy, Reiter's syndrome, or gout involving the knee; and current use of anticoagulants. Radiographic Imaging: Posteroanterior semi-flexed knee radiographs were obtained and read for Kellgren Lawrence (KL) grade 3 and individual radiographic features of OA, including joint space narrowing (JSN) and osteophytes (OST).
Scintigraphic Imaging: Scintigraphic images of the knee were obtained at 2 minutes (early phase) and 2.5 hours (late phase) after injection of technetium-99m methylene diphosphonate. A single anteroposterior view was obtained at 2 minutes, and four views of the knee were obtained at 2.5 hours. The intensity of bone uptake was scored for the medial (Med) and lateral (Lat) compartments of each knee, and 12 other joint sites: shoulders, elbows, wrists, hands, hips, sacroiliac, ankles, forefeet, cervical spine, thoracic spine and lumbar spine, and sternoclavicular and sternomanubrial joints. Total bone scan scores include these 12 sites plus the knees.
Uric acid quantification: Matched serum and SF samples were analyzed for uric acid using a previously described HPLC assay 4 .
COMP and Cytokine quantification in the synovial fluid: Cartilage oligomeric matrix protein (COMP), a marker of cartilage degeneration that correlates with degree of histological OA in animal models 5 , was measured using an in-house sandwich ELISA as previously described 6 . All cytokines were measured in the synovial fluids using a commercially available (Linco, St. Charles Missouri) human cytokine multiplex immunoassay for IL-5, IL-6, IL-7, IL-8, IL-13, MCP-1, and MIP-1 beta.
Statistical Analysis: Descriptive statistics and univariate analyses were performed using Graphpad Prism software (San Diego, CA). Relationships between SF analytes and OA were analyzed using the GenMOD procedure with the addition of a repeated statement (GLM, SAS Enterprise Guide, Cary, NC). Multivariate modeling was used to assess independent effects of SF analytes and to control for BMI, age, and gender.
RESULTS
This study was limited to 69 study participants (49 women and 20 men) with knee OA and adequate SF volume for these analyses. The mean (+SD) age was 64.5±10.1 years. The mean (+SD) body mass index was 32.4±7.1 kg/m 2 . Knee OA was graded 1-4 in severity (23.1%, 14.6%, 49.2%, 13.1% for each KL grade). SF measurements were possible for both knees of 63 participants, and for single knees of 6 participants. The mean uric acid (+SD) was 6.43+1.75 mg/dl for serum, 5.17+1.79 mg/dl for the right knee SF, and 4.93+1.95 mg/dl for the left knee SF. Synovial fluid, but not serum uric acid, was positively associated with all three measures of OA severity. Serum uric acid was consistently higher than synovial fluid uric acid in nearly all individuals. Synovial fluid uric acid was also associated with synovial fluid IL-8, a marker of inflammation associated with macrophage activation, and synovial fluid COMP, a marker of cartilage degradation, but did not correlate with other markers in the cytokine panel
DISCUSSION
The strong association shown here between OA severity and synovial fluid uric acid, demonstrates that uric acid is a marker of joint tissue injury and raises the strong possibility that uric acid may be a factor contributing to the pathological process of OA. The constitutive release of uric acid from injured and dying cells in the OA joint may exacerbate joint tissue inflammation through sub-acute macrophage activation. It is also possible that urate crystallization in the presence of nucleating agents released from degrading cartilage extracellular matrix may also contribute to this process.
